
Peter Palese, Mount Sinai School of Medicine, New York, NY, USA
Adolfo García-Sastre, Mount Sinai School of Medicine, New York, NY, USA
Lakshmi Goyal, Editor, Cell Host & Microbe
Julie Stacey, Senior Editor, Immunity
Given the recent influenza pandemic, the last 12 months have seen a flurry of activity in the area of flu research. New insights are being gained about the biology of the virus, the host immune response, and the ability of the virus to overcome species barriers and host-immune defenses. The broader goal of influenza research is to extrapolate these basic insights for better control of disease, and to develop better vaccines and anti-viral therapeutics. This meeting aims to foster interactions among a broad group of scientists studying the influenza virus from multiple perspectives including: the virus itself, the host response to viral infection, the clinical manifestations of pandemic and seasonal influenza, as well as those scientists actively working to develop better vaccines and therapeutics in an industrial setting.
This meeting aims to bring basic scientists, clinicians, epidemiologists and applied biotechnology and pharmaceutical researchers together to build a translational bridge between basic influenza research and the development of drugs, vaccines and diagnostics for the flu.
Rafi Ahmed, Emory University School of Medicine, Atlanta, GA
Adolfo Garcia-Sastre, Mount Sinai School of Medicine, New York, NY
Ronald Germain, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD
Frederick G Hayden, The Wellcome Trust, London and University of Virginia, Charlottesville, VA
Akiko Iwasaki, Yale School of Medicine, New Haven, CT
Yoshihiro Kawaoka, University of Wisconsin-Madison, USA and The University of Tokyo, Japan
Hans-Dieter Klenk, Philipps-Universität Marburg, Germany
Marc Lipsitch, Harvard School of Public Health, Boston, MA
Jonathan McCullers, St. Jude Children's Research Hospital, Memphis, TN
Peter Palese, Mount Sinai School of Medicine, New York, NY
Megan Shaw, Mount Sinai School of Medicine, New York, NY
Kanta Subbarao, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD
Terrence Tumpey, Centers for Disease Control & Prevention, Atlanta, GA
David Woodland, Trudeau Institute, Saranac Lake, NY
Makoto Yamashita, Biological Research Laboratories IV, Daiichi Sankyo Co. Ltd., Tokyo, Japan
Please submit abstracts for presentation at the symposium by July 31, 2010.
Cell Host & Microbe provides a forum for the exchange of ideas and concepts between scientists studying the microbe with those studying the host immune and cell biological response upon colonization or infection by a microbe. The journal publishes on a wide range of topics related to microbes (which includes bacteria, fungi, parasites and viruses), from molecular and cellular biology to translational studies with particular emphasis on the interface between the microbe and its host (vertebrate, invertebrate or plant).
Cell is the premier journal of the life sciences, publishing the highest quality research across a broad range of disciplines. Cell’s distinctive narrative format provides authors with enough space to tell a full and complete story and creates a unique opportunity to promote interdisciplinary thinking across fields. The combination of editorial excellence and full-length presentation ensures the value of Cell both to its authors who know their work will be seen and appreciated by a broad readership and to its readers who can inform their own research with conceptual advances from other fields.
As one of the highest impact journals in its field, Immunity provides a prestigious forum for the discussion of various topics across the domain of immunology. Subjects encompass all aspects of the immune system, focusing on fundamental principles and mechanistic insight for the molecular and cellular immunology of infectious and autoimmune diseases, allergy, transplantation, and cancer.
